Most centralized AI labs would market any one of these as a quarterly headline, yet Bittensor’s subnets cleared four of them inside a single 24-hour window.
The work spanned model training, genomics, frontier inference, and drug discovery, each coordinated through the same incentive layer rather than a co-located cluster.
Let’s explore each of these milestones:
IOTA (SN9) Runs the Largest Decentralized Pipeline-Parallel Training Job on Record
IOTA, built by Macrocosmos on Subnet 9, kicked off a 16.2-billion-parameter pipeline-parallel training run spread across 10 stages and 18 replicas, extending the trajectory its earlier Orion-100B experiments established.
Those runs already showed that frontier-scale models can train across globally distributed, heterogeneous GPUs over commodity internet at roughly 65% of datacenter speeds on 100B-scale workloads.
And the subnet has decided to build all these in open, according to the public dashboard they recently launched:
Minos (SN107) Lands a Co-Authored Paper with OpenAI
Minos, the genomics-focused subnet, co-authored research with OpenAI on scientific computing in the age of agentic AI, with its HelixForge system featured as one of the most complex case studies in the paper.
HelixForge is a GPU-native engine for generating synthetic genomes, and on matched benchmarks it delivered roughly 60x end-to-end speedups over older CPU workflows.
Think about this. A Bittensor subnet’s core technology now sits alongside OpenAI’s own work on agentic scientific tooling.
Minos is building the foundational layer for accurate, incentivized DNA variant calling, and once decentralized genomics infrastructure starts showing up in OpenAI papers, the argument that crypto AI is pure narrative gets much harder to hold.
Read more about Minos here.
Engy (SN53) Serves Full Kimi K3 on 80 RTX 4090s
Engy demonstrated the full 2.8-trillion-parameter Kimi K3, Moonshot’s open frontier model with a 1M-token context window, running across a fleet of 80 consumer RTX 4090s.
Kimi K3 ranks among the largest open-weight models ever released and competes with top closed models on coding and reasoning benchmarks, so serving it on abundant gaming GPUs rather than scarce HBM-heavy datacenter silicon is a direct proof of decentralized inference at frontier scale.
Read more about Engy here.
Metanova (SN68) Moves Nanobodies into Wet-Lab Production with Yalotein
Metanova Labs (SN68) announced the start of experimental nanobody production in partnership with Yalotein, with top candidates from competitive virtual screening now entering wet-lab validation.
This achievement is a feat most AI drug-discovery projects never reach, moving from AI-generated designs to actual biological molecules under experimental feedback.
NOVA now runs parallel tracks for small molecules and nanobodies under one incentive system, which turns decentralized prediction into a multi-modal drug-discovery engine.
Read more about it here.
Why the Market is Yet to Price All These In
Four milestones in one day, across large-model training, genomics, frontier inference, and therapeutics, mark the exact domains that will define the next decade of AI value.
Centralized labs still hold real advantages in capital and market concentration, but they cannot replicate the permissionless coordination, economic alignment, and global hardware utilization that these subnets already run in production.
Bittensor is shipping measurable capability while much of the market is still debating whether decentralized AI is even feasible, and the distance between those two positions is now wide enough to trade on.
Enjoyed this article? Join our newsletter
Get the latest TAO & Bittensor news straight to your inbox.
We respect your privacy. Unsubscribe anytime.
Enjoyed this article?
Join our newsletter
Get the latest TAO & Bittensor news straight to your inbox — every morning before markets open.





Be the first to comment